This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 Aug;608(7922):258-260.

doi: 10.1038/d41586-022-02140-w.

Long-COVID treatments: why the world is still waiting

PMID: 35945375
DOI: 10.1038/d41586-022-02140-w

Long-COVID treatments: why the world is still waiting

Heidi Ledford. Nature. 2022 Aug.

. 2022 Aug;608(7922):258-260.

doi: 10.1038/d41586-022-02140-w.

Author

PMID: 35945375
DOI: 10.1038/d41586-022-02140-w

No abstract available

Keywords: Drug discovery; Medical research; SARS-CoV-2.

PubMed Disclaimer

Similar articles

COVID-19 long haulers.
Schmidt C. Schmidt C. Nat Biotechnol. 2021 Aug;39(8):908-913. doi: 10.1038/s41587-021-00984-7. Nat Biotechnol. 2021. PMID: 34257426 Free PMC article.
Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2.
Goudarzi S, Dehghani Firouzabadi F, Dehghani Firouzabadi M, Rezaei N. Goudarzi S, et al. Dermatol Ther. 2020 Nov;33(6):e14266. doi: 10.1111/dth.14266. Epub 2020 Sep 14. Dermatol Ther. 2020. PMID: 32882081 No abstract available.
Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection.
Soriano V, Moreno-Torres V. Soriano V, et al. Lancet Infect Dis. 2024 Oct;24(10):1066-1067. doi: 10.1016/S1473-3099(24)00258-5. Epub 2024 May 3. Lancet Infect Dis. 2024. PMID: 38710191 No abstract available.
Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs Against COVID-19.
Ünlü B, Simsek R, Köse SBE, Yirün A, Erkekoglu P. Ünlü B, et al. Mini Rev Med Chem. 2022;22(2):213-231. doi: 10.2174/1389557521666210629100630. Mini Rev Med Chem. 2022. PMID: 34191697 Review.
Two years into COVID-19 - Lessons in SARS-CoV-2 and a perspective from papers in FEBS Letters.
Greber UF. Greber UF. FEBS Lett. 2021 Dec;595(23):2847-2853. doi: 10.1002/1873-3468.14226. Epub 2021 Nov 16. FEBS Lett. 2021. PMID: 34787897 Free PMC article. Review.

See all similar articles

Cited by

Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase.
Wan EYF, Wang B, Mathur S, Chan CIY, Yan VKC, Lai FTT, Chui CSL, Li X, Wong CKH, Li PH, Lau CS, Wong ICK, Chan EWY. Wan EYF, et al. J Infect. 2023 Jun;86(6):622-625. doi: 10.1016/j.jinf.2023.02.029. Epub 2023 Feb 22. J Infect. 2023. PMID: 36822409 Free PMC article. No abstract available.
Frailty after COVID-19: The wave after?
König M, Gollasch M, Komleva Y. König M, et al. Aging Med (Milton). 2023 Jun 28;6(3):307-316. doi: 10.1002/agm2.12258. eCollection 2023 Sep. Aging Med (Milton). 2023. PMID: 37711259 Free PMC article. Review.
Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan.
Tsuchida T, Yoshimura N, Ishizuka K, Katayama K, Inoue Y, Hirose M, Nakagama Y, Kido Y, Sugimori H, Matsuda T, Ohira Y. Tsuchida T, et al. Clin Exp Med. 2023 Nov;23(7):3663-3670. doi: 10.1007/s10238-023-01057-6. Epub 2023 Apr 7. Clin Exp Med. 2023. PMID: 37027067 Free PMC article.
Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116).
Cao Q, Ding Y, Xu Y, Li M, Zheng R, Cao Z, Wang W, Bi Y, Ning G, Xu Y, Zhao R. Cao Q, et al. Front Med. 2023 Dec;17(6):1068-1079. doi: 10.1007/s11684-023-1037-3. Epub 2024 Jan 2. Front Med. 2023. PMID: 38165534 Review.
Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial.
Hadanny A, Zilberman-Itskovich S, Catalogna M, Elman-Shina K, Lang E, Finci S, Polak N, Shorer R, Parag Y, Efrati S. Hadanny A, et al. Sci Rep. 2024 Feb 15;14(1):3604. doi: 10.1038/s41598-024-53091-3. Sci Rep. 2024. PMID: 38360929 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Davis, H. E. et al. eClinicalMedicine 38, 101019 (2021). - PubMed - DOI - PMC
1. Pretorius, E. et al. Cardiovasc. Diabetol. 20, 172 (2021). - PubMed - DOI - PMC
1. Pretorius, E. et al. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-1205453/v1 (2021).
1. Ayoubkhani, D. et al. BMJ 377, e069676 (2022). - PubMed - DOI
1. Imai, K. et al. Viruses 14, 907 (2022). - PubMed - DOI - PMC

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal